["{\n\"step_by_step_thinking\": \"The question describes a 1-month-old girl with normocytic anemia, elevated reticulocyte count, and decreased haptoglobin. These findings suggest a hemolytic process. The Coombs test is negative, ruling out immune-mediated hemolysis. Sickle cell anemia and other hemoglobinopathies are also ruled out. A Coombs test is negative. Red blood cell osmotic fragility gap is normal. This suggests that the enzyme deficiency causing the hemolysis is not related to membrane stability or sickling.\n\nConsidering the fact that the patient has a family history of requiring blood transfusions, it is likely that the patient has an inherited disorder. The finding of normocytic anemia and elevated reticulocyte count suggests that the enzyme deficiency leads to premature destruction of red blood cells.\n\nThe options provided are all metabolic intermediates or regulators. Given the context of the question, the most plausible answer is that this enzyme is inhibited by one of these metabolic products. Fructose 1,6-bisphosphate and fructose 2,6-bisphosphate are both allosteric inhibitors of glyceraldehyde-3-phosphate dehydrogenase, an enzyme involved in glycolysis.\n\nTherefore, based on the context and the options provided, it is likely that this enzyme deficiency is caused by a defect in the glyceraldehyde-3-phosphate dehydrogenase enzyme.\",\n\"answer_choice\": D"]